A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 1994

Study Completion Date

February 28, 2001

Conditions

Breast CancerBreast Neoplasms

Interventions

DRUG

Adriamycin

DRUG

cyclophosphamide

DRUG

G-CSF

DRUG

paclitaxel

Trial Locations (1)

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH